BIM
GMAB icon

Bogle Investment Management’s Genmab GMAB Stock Holding History

Bogle Investment Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-56,804
Closed -$2.08M – 194
2020
Q3 		$2.08M Buy
56,804
+4,242
+8% +$153K 0.61% 83
2020
Q2 		$1.78M Sell
52,562
-72,526
-58% -$1.98M 0.3% 141
2020
Q1 		$2.65M Buy
125,088
+37,617
+43% +$839K 0.28% 105
2019
Q4 		$1.95M Buy
+87,471
New +$1.91M 0.18% 143

Other funds holding GMAB

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bogle Investment Management's GMAB Position: Q4 2020 in Review

Bogle Investment Management sold out of Genmab (GMAB) in Q4 2020, closing a stake of 56,804 shares — an estimated $2.08M sold.

Bogle Investment Management first reported a position in GMAB in Q4 2019 and held it in 4 quarters. The position peaked at $2.65M in Q1 2020. 227 funds tracked by Wall St. Rank hold GMAB as of Q4 2020.

  • Bogle Investment Management reported no remaining Genmab position as of Q4 2020 after selling out during the quarter.
  • Bogle Investment Management sold 56,804 Genmab shares in Q4 2020, an estimated $2.08M.
  • Bogle Investment Management first reported a position in Genmab in Q4 2019 and held it in 4 quarters.
  • Bogle Investment Management's Genmab position peaked at $2.65M in Q1 2020.
  • 227 funds tracked by Wall St. Rank held Genmab as of Q4 2020.

Based on Bogle Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.